Dexilant and Infusion site bruising - a phase IV clinical study of FDA data

Summary:

Infusion site bruising is reported as a side effect among people who take Dexilant (dexlansoprazole), especially for people who are female, 30-39 old, also take Epinephrine, and have Immunodeficiency common variable.

The phase IV clinical study analyzes which people have Infusion site bruising when taking Dexilant. It is created by eHealthMe based on reports of 56,153 people who have side effects when taking Dexilant from the FDA, and is updated regularly.

What is Dexilant?

Dexilant has active ingredients of dexlansoprazole. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 57,103 Dexilant users. Check the latest studies of Dexilant.

What is Infusion site bruising?

Infusion site bruising is found to be associated with 413 drugs and 183 conditions by eHealthMe. Check the latest studies of Infusion site bruising.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

56,153 people reported to have side effects when taking Dexilant.
Among them, 29 people (0.05%) have Infusion site bruising.

Could Dexilant cause Infusion site bruising?

Among these 29 people:

What is the gender of people who have Infusion site bruising when taking Dexilant? *

female: 85.71 %
male: 14.29 %

What is the age of people who have Infusion site bruising when taking Dexilant? *

What are other drugs people take besides Dexilant? *

What are other side effects people have besides Infusion site bruising? *

Infection: 15 people, 51.72%
Fatigue (feeling of tiredness): 14 people, 48.28%
Malaise (a feeling of general discomfort or uneasiness): 11 people, 37.93%
Sinusitis (inflammation of sinus): 11 people, 37.93%
Infusion Site Discomfort: 11 people, 37.93%
Infusion Site Swelling: 11 people, 37.93%
Nausea (feeling of having an urge to vomit): 10 people, 34.48%
Infusion Site Erythema (reddening of the skin at infusion site): 10 people, 34.48%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 10 people, 34.48%
Respiratory Tract Infection: 10 people, 34.48%

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 16 people, 55.17%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 17.24%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 10.34%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 10.34%
Myelitis Transverse (a neurological condition consisting of an inflammatory process of the spinal cord): 2 people, 6.90%
Encephalomyelitis (inflammation of the brain and spinal cord): 2 people, 6.90%
Encephalitis (inflammation of the brain): 2 people, 6.90%
Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function): 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Dexilant and have Infusion site bruising?

- Check whether Infusion site bruising is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dexilant:

Dexilant (57,103 reports)

Browse all side effects of Dexilant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Infusion site bruising:

Infusion site bruising (413 drugs)

Browse all the conditions that are associated with Infusion site bruising:

Infusion site bruising (183 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dexlansoprazole (the active ingredients of Dexilant) and Dexilant (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.